chrX-38094302-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_138780.3(SYTL5):c.839G>A(p.Gly280Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000501 in 1,197,554 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 20 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138780.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SYTL5 | NM_138780.3 | c.839G>A | p.Gly280Asp | missense_variant | 8/17 | ENST00000297875.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SYTL5 | ENST00000297875.7 | c.839G>A | p.Gly280Asp | missense_variant | 8/17 | 5 | NM_138780.3 | P4 | |
SYTL5 | ENST00000456733.2 | c.839G>A | p.Gly280Asp | missense_variant | 7/17 | 1 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000297 AC: 33AN: 111133Hom.: 0 Cov.: 22 AF XY: 0.000210 AC XY: 7AN XY: 33391
GnomAD3 exomes AF: 0.0000493 AC: 9AN: 182426Hom.: 0 AF XY: 0.0000596 AC XY: 4AN XY: 67058
GnomAD4 exome AF: 0.0000249 AC: 27AN: 1086373Hom.: 0 Cov.: 28 AF XY: 0.0000367 AC XY: 13AN XY: 353955
GnomAD4 genome AF: 0.000297 AC: 33AN: 111181Hom.: 0 Cov.: 22 AF XY: 0.000209 AC XY: 7AN XY: 33449
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 21, 2024 | The c.839G>A (p.G280D) alteration is located in exon 8 (coding exon 7) of the SYTL5 gene. This alteration results from a G to A substitution at nucleotide position 839, causing the glycine (G) at amino acid position 280 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at